Salas A - Search Results

1

Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.

Casadó-Llombart S, Velasco-de Andrés M, Català C, Leyton-Pereira A, Gutiérrez-Cózar R, Suárez B, Armiger N, Carreras E, Esteller M, Ricart E, Ordás I, Gisbert JP, Chaparro M, Esteve M, Márquez L, Busquets D, Iglesias E, García-Planella E, Martín-Arranz MD, Lohmann J, Ayata CK, Niess JH, Engel P, Panés J, Salas A, Domènech E, Lozano F; ENEIDA Project of GETECCU. Casadó-Llombart S, et al. Among authors: salas a. Front Immunol. 2022 Sep 21;13:966184. doi: 10.3389/fimmu.2022.966184. eCollection 2022. Front Immunol. 2022. PMID: 36211446 Free PMC article.

2

Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice.

Salas A, Gironella M, Salas A, Soriano A, Sans M, Iovanna J, Piqué JM, Panés J. Salas A, et al. Lab Invest. 2002 May;82(5):597-607. doi: 10.1038/labinvest.3780454. Lab Invest. 2002. PMID: 12004000 Free article.

3

The role of P-selectin in experimental colitis as determined by antibody immunoblockade and genetically deficient mice.

Gironella M, Mollà M, Salas A, Soriano A, Sans M, Closa D, Engel P, Salas A, Piqué JM, Panés J. Gironella M, et al. Among authors: salas a. J Leukoc Biol. 2002 Jul;72(1):56-64. J Leukoc Biol. 2002. PMID: 12101263

4

Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis.

Panés J, Aceituno M, Gil F, Miquel R, Piqué JM, Salas A, McLean P. Panés J, et al. Among authors: salas a. Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G739-48. doi: 10.1152/ajpgi.00059.2007. Epub 2007 Jul 26. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17656448 Free article.

5

Defective IL-10 production in severe phenotypes of Crohn's disease.

Correa I, Veny M, Esteller M, Piqué JM, Yagüe J, Panés J, Salas A. Correa I, et al. Among authors: salas a. J Leukoc Biol. 2009 May;85(5):896-903. doi: 10.1189/jlb.1108698. Epub 2009 Feb 23. J Leukoc Biol. 2009. PMID: 19237638 Free article.

6

Mechanisms underlying the beneficial effects of stem cell therapies for inflammatory bowel diseases.

Panés J, Salas A. Panés J, et al. Among authors: salas a. Gut. 2009 Jul;58(7):898-900. doi: 10.1136/gut.2008.175067. Gut. 2009. PMID: 19520885 No abstract available.

7

Cell therapies for inflammatory bowel diseases.

Salas A, Ricart E, Panés J. Salas A, et al. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):321-4. doi: 10.1586/egh.09.26. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19673617 Free article. No abstract available.

8

Defects in autophagy induce alterations in the secretory pathway and proinflammatory signaling of paneth cells.

Salas A, Panés J. Salas A, et al. Gastroenterology. 2009 Oct;137(4):1527-9. doi: 10.1053/j.gastro.2009.08.021. Epub 2009 Aug 28. Gastroenterology. 2009. PMID: 19717131 No abstract available.

9

The 2-phase model of Crohn's disease: from immune defect to hyperresponse.

Salas A, Panés J. Salas A, et al. Gastroenterology. 2010 Mar;138(3):1204-6; discussion 1207. doi: 10.1053/j.gastro.2010.01.025. Epub 2010 Jan 25. Gastroenterology. 2010. PMID: 20100444 No abstract available.

10

[Rationale for cell therapy in the treatment of inflammatory bowel disease].

Ordás I, Salas A, Benítez D, Ricart E, Panés J. Ordás I, et al. Among authors: salas a. Gastroenterol Hepatol. 2010 Dec;33(10):716-20. doi: 10.1016/j.gastrohep.2010.01.003. Epub 2010 Apr 8. Gastroenterol Hepatol. 2010. PMID: 20381204 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

932 results

Search Page